Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive malignant smooth muscle neoplasm, arising from the skin. It is characterized by a proliferation of neoplastic spindle cells.
Biomarker and diagnostic research for cutaneous leiomyosarcoma has been reported in the published literature.
No clinical trials have been registered for cutaneous leiomyosarcoma.
62 publications have been identified in PubMed for cutaneous leiomyosarcoma. Research spans Case Report / Case Series (40%), Review / Meta-Analysis (17%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 23 | 40% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
10 |
17% |
Disease patterns and progression | 8 | 14% |
Other research | 6 | 10% |
Testing and diagnosis research | 5 | 9% |
Clinical study results | 3 | 5% |
Laboratory research | 3 | 5% |
Hill J (2026). [PMID: 41551622](https://pubmed.ncbi.nlm.nih.gov/41551622/). *JAAD Case Rep*. [Case Report / Case Series]
Joshi TP (2026). [PMID: 40720846](https://pubmed.ncbi.nlm.nih.gov/40720846/). *Dermatol Surg*. [Epidemiology / Natural History]
Kim YH (2026). [PMID: 42103181](https://pubmed.ncbi.nlm.nih.gov/42103181/). *J Am Acad Dermatol*. [Clinical Trial Publication]
Joshi TP (2026). [PMID: 42130007](https://pubmed.ncbi.nlm.nih.gov/42130007/). *Int J Dermatol*. [Review / Meta-Analysis]
Lenz J (2026). [PMID: 41631521](https://pubmed.ncbi.nlm.nih.gov/41631521/). *Vet Med Sci*. [Case Report / Case Series]
Aiba H (2026). [PMID: 42204032](https://pubmed.ncbi.nlm.nih.gov/42204032/). *Int J Clin Oncol*. [Epidemiology / Natural History]
Khawaja AA (2026). [PMID: 42254216](https://pubmed.ncbi.nlm.nih.gov/42254216/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Hoang M (2026). [PMID: 41711635](https://pubmed.ncbi.nlm.nih.gov/41711635/). *Am J Dermatopathol*. [Case Report / Case Series]
Lingo JJ (2026). [PMID: 41727100](https://pubmed.ncbi.nlm.nih.gov/41727100/). *bioRxiv*. [Diagnostic / Biomarker]
Joshi TP (2026). [PMID: 40626608](https://pubmed.ncbi.nlm.nih.gov/40626608/). *Dermatol Surg*. [Diagnostic / Biomarker]
AI-curated news mentioning cutaneous leiomyosarcoma
Updated Sep 16, 2026
A multicenter retrospective study in Spain analyzed 39 cases of primary cutaneous leiomyosarcomas, detailing their clinicopathologic features and outcomes. This research contributes to the understanding of this rare skin cancer, which may inform future treatment approaches.